Suppr超能文献

开展调查和在线讨论组,以制定一项关于白癜风治疗反应可接受性的患者自评结局指标。

Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo.

作者信息

Tour Selina K, Thomas Kim S, Walker Dawn-Marie, Leighton Paul, Yong Adrian Sw, Batchelor Jonathan M

机构信息

Centre of Evidence Based Dermatology, The University of Nottingham, Nottingham, UK.

出版信息

BMC Dermatol. 2014 Jun 14;14:10. doi: 10.1186/1471-5945-14-10.

Abstract

BACKGROUND

Vitiligo is a chronic depigmenting skin disorder which affects around 0.5-1% of the world's population. The outcome measures used most commonly in trials to judge treatment success focus on repigmentation. Patient-reported outcome measures of treatment success are rarely used, although recommendations have been made for their inclusion in vitiligo trials. This study aimed to evaluate the face validity of a new patient-reported outcome measure of treatment response, for use in future trials and clinical practice.

METHOD

An online survey to gather initial views on what constitutes treatment success for people with vitiligo or their parents/carers, followed by online discussion groups with patients to reach consensus on what constitutes treatment success for individuals with vitiligo, and how this can be assessed in the context of trials. Participants were recruited from an existing database of vitiligo patients and through posts on the social network sites Facebook and Twitter.

RESULTS

A total of 202 survey responses were received, of which 37 were excluded and 165 analysed. Three main themes emerged as important in assessing treatment response: a) the match between vitiligo and normal skin (how well it blends in); b) how noticeable the vitiligo is and c) a reduction in the size of the white patches. The majority of respondents said they would consider 80% or more repigmentation to be a worthwhile treatment response after 9 months of treatment. Three online discussion groups involving 12 participants led to consensus that treatment success is best measured by asking patients how noticeable their vitiligo is after treatment. This was judged to be best answered using a 5-point Likert scale, on which a score of 4 or 5 represents treatment success.

CONCLUSIONS

This study represents the first step in developing a patient reported measure of treatment success in vitiligo trials. Further work is now needed to assess its construct validity and responsiveness to change.

摘要

背景

白癜风是一种慢性色素脱失性皮肤病,影响着全球约0.5%-1%的人口。在试验中最常用于判断治疗成功的结局指标侧重于色素再生。尽管已有建议将患者报告的治疗成功结局指标纳入白癜风试验,但此类指标很少被使用。本研究旨在评估一种新的患者报告的治疗反应结局指标的表面效度,以便用于未来的试验和临床实践。

方法

开展一项在线调查,收集白癜风患者或其父母/照料者对于治疗成功的构成要素的初步看法,随后与患者进行在线讨论组,就白癜风患者治疗成功的构成要素以及如何在试验背景下对此进行评估达成共识。参与者从现有的白癜风患者数据库以及通过在社交网站脸书和推特上发布招募信息来招募。

结果

共收到202份调查问卷回复,其中37份被排除,165份进行分析。在评估治疗反应时出现了三个重要的主要主题:a)白癜风与正常皮肤的匹配度(融合程度);b)白癜风的显眼程度;c)白色斑块大小的缩小。大多数受访者表示,他们会认为治疗9个月后色素再生80%或更多是值得的治疗反应。三个涉及12名参与者的在线讨论组达成共识,即通过询问患者治疗后白癜风的显眼程度来衡量治疗成功是最佳方法。判断这一问题的最佳回答方式是使用5级李克特量表,其中4分或5分代表治疗成功。

结论

本研究是在白癜风试验中开发患者报告的治疗成功指标的第一步。现在需要进一步开展工作来评估其结构效度和对变化的反应性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92fe/4075774/64077e321b36/1471-5945-14-10-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验